| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AN2 Therapeutics, Inc. | Director | Common Stock | 8,610 | $10,133 | $1.18 | 28 May 2025 | Direct |
| AN2 Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 19,111 | 22 May 2025 | Direct | ||
| Vistagen Therapeutics, Inc. | Director | Non-Qualified Stock Option (right to buy) | 17,600 | 09 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VTGN | Vistagen Therapeutics, Inc. | 09 Sep 2025 | 1 | $0 | 4 | Director | 11 Sep 2025, 18:15 |
| ANTX | AN2 Therapeutics, Inc. | 28 May 2025 | 1 | +$10,133 | 4 | Director | 29 May 2025, 16:17 |
| ANTX | AN2 Therapeutics, Inc. | 22 May 2025 | 1 | $0 | 4 | Director | 23 May 2025, 16:59 |
| VTGN | Vistagen Therapeutics, Inc. | 06 Sep 2024 | 1 | $0 | 4 | Director | 10 Sep 2024, 17:00 |
| ANTX | AN2 Therapeutics, Inc. | 19 Jun 2024 | 1 | $0 | 4 | Director | 21 Jun 2024, 18:18 |
| VTGN | Vistagen Therapeutics, Inc. | 04 Mar 2024 | 1 | $0 | 4 | Director | 06 Mar 2024, 18:00 |
| ANTX | AN2 Therapeutics, Inc. | 07 Jun 2023 | 1 | $0 | 4 | Director | 09 Jun 2023, 20:54 |
| ANTX | AN2 Therapeutics, Inc. | 12 May 2022 | 1 | $0 | 4 | Director | 16 May 2022, 21:20 |
| ANTX | AN2 Therapeutics, Inc. | 05 May 2022 | 1 | $0 | 4 | Director | 09 May 2022, 21:39 |
| ANTX | AN2 Therapeutics, Inc. | 05 May 2022 | 0 | $0 | 3 | Director | 09 May 2022, 21:29 |
| VTGN | VistaGen Therapeutics, Inc. | 01 Mar 2022 | 1 | $0 | 4 | Director | 03 Mar 2022, 15:13 |
| VTGN | VistaGen Therapeutics, Inc. | 21 Jul 2021 | 1 | $0 | 4 | Director | 22 Jul 2021, 16:11 |
| VTGN | VistaGen Therapeutics, Inc. | 21 Jul 2021 | 0 | $0 | 3 | Director | 22 Jul 2021, 16:09 |